Data / Drug companies / Bisacodyl
Bisacodyl: 60 companies and 112 products in the FDA NDC directory
Bisacodyl is listed in the FDA National Drug Code Directory by 60 companies, with 112 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, delayed release; suppository; tablet, coated, and the newest product started marketing on October 21, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 60
- Products
- 112
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 5
- Routes
- Oral, Rectal
- Brand names
- Gentle Laxative, Laxative, Stimulant Laxative Enteric Coated, Womens Gentle Laxative, CVS Gentle Laxative, Laxative Gentle, Womens Laxative, Womens Gentle Laxative
- openFDA record search
- api.fda.gov
Companies that list bisacodyl
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Chattem, Inc. | 6 | tablet, coated; tablet, film coated | Over the counter monograph drugs | February 21, 2025 |
| CVS Pharmacy | 5 | suppository; tablet, delayed release | Over the counter monograph drugs | September 16, 2015 |
| Dolgencorp, Inc. (dollar General & Rexall) | 5 | tablet, delayed release; suppository | Over the counter monograph drugs | July 24, 2025 |
| Amerisource Bergen | 4 | tablet, delayed release; suppository | Over the counter monograph drugs | June 26, 2019 |
| Cardinal Health 110, LLC. DBA Leader | 4 | tablet, delayed release; tablet | Over the counter monograph drugs | May 19, 2021 |
| Safeway | 4 | tablet; tablet, delayed release | Over the counter monograph drugs | October 21, 2026 |
| H E B | 3 | tablet, delayed release; suppository | Over the counter monograph drugs | September 10, 2024 |
| Major Pharmaceuticals | 3 | tablet, delayed release; suppository | Over the counter monograph drugs | May 5, 2021 |
| Rite Aid Corporation | 3 | tablet, delayed release; suppository | Over the counter monograph drugs | November 14, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet; tablet, delayed release | Over the counter monograph drugs | December 1, 2018 |
| Bi-Mart | 2 | tablet, delayed release; tablet | Over the counter monograph drugs | August 1, 2025 |
| Bryant Ranch Prepack | 2 | tablet; tablet, delayed release | Over the counter monograph drugs | December 1, 2018 |
| C.B. Fleet Company, Inc. | 2 | tablet, coated; enema | Over the counter monograph drugs | June 21, 2024 |
| CVS Pharmacy | 2 | tablet, coated; suppository | Over the counter monograph drugs | April 14, 2021 |
| Chain Drug Consortium, LLC | 2 | suppository; tablet, delayed release | Over the counter monograph drugs | June 3, 2019 |
| Chain Drug Marketing Association | 2 | tablet, coated; tablet, delayed release | Over the counter monograph drugs | February 17, 2020 |
| Chain Drug Marketing Association, Inc. | 2 | tablet, delayed release | Over the counter monograph drugs | June 30, 2025 |
| Discount Drug Mart | 2 | suppository; tablet, delayed release | Over the counter monograph drugs | December 2, 2024 |
| Family Dollar (family Wellness) | 2 | tablet, delayed release | Over the counter monograph drugs | January 10, 2024 |
| Geri-Care Pharmaceuticals, Corp | 2 | tablet; suppository | Over the counter monograph drugs | November 1, 2019 |
| HHH Pharmaceuticals | 2 | tablet, delayed release | Over the counter monograph drugs | July 2, 2026 |
| Kroger Company | 2 | tablet, coated; tablet | Over the counter monograph drugs | June 1, 2020 |
| Meijer Distribution Inc | 2 | suppository; tablet, delayed release | Over the counter monograph drugs | June 29, 2020 |
| Perrigo Direct, Inc | 2 | tablet, delayed release | Over the counter monograph drugs | July 17, 2026 |
| Publix Super Markets Inc | 2 | tablet, delayed release | Over the counter monograph drugs | May 21, 2024 |
| Publix Super Markets, Inc | 2 | tablet, coated; tablet | Over the counter monograph drugs | May 22, 2019 |
| Rising Pharma Holdings, Inc. | 2 | suppository; tablet, coated | Over the counter monograph drugs | October 10, 2026 |
| Strategic Sourcing Services LLC | 2 | tablet, delayed release; suppository | Over the counter monograph drugs | April 15, 2023 |
| Strive Pharmaceuticals Inc. | 2 | tablet, coated; tablet | Over the counter monograph drugs | April 25, 2025 |
| Target Corporation | 2 | tablet; tablet, coated | Over the counter monograph drugs | April 1, 2019 |
| Wal-Mart Stores Inc | 2 | tablet, delayed release | Over the counter monograph drugs | December 17, 2019 |
| Walgreen Company | 2 | tablet, delayed release | Over the counter monograph drugs | September 16, 2015 |
| WinCo Foods, LLC | 2 | tablet, delayed release | Over the counter monograph drugs | July 17, 2024 |
| Aarna USA Inc. | 1 | suppository | Over the counter monograph drugs | April 21, 2026 |
| Advanced Rx LLC | 1 | tablet, delayed release | Over the counter monograph drugs | January 1, 2025 |
| Akron Pharma Inc. | 1 | suppository | Over the counter monograph drugs | September 13, 2024 |
| Bionpharma Inc. | 1 | tablet, delayed release | Over the counter monograph drugs | February 23, 2026 |
| Bliss GVS Pharma Limited | 1 | suppository | Over the counter monograph drugs | December 16, 2018 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | tablet, delayed release | Over the counter monograph drugs | July 7, 2026 |
| Cardinal Health 107, LLC | 1 | tablet, delayed release | Over the counter monograph drugs | March 25, 2002 |
| Graxcell Pharmaceutical, LLC | 1 | suppository | Over the counter monograph drugs | March 29, 2017 |
| HyVee Inc | 1 | tablet | Over the counter monograph drugs | August 20, 2026 |
| InvaDerm Corporation | 1 | suppository | Over the counter monograph drugs | September 1, 2026 |
| Kroger Company | 1 | tablet, delayed release | Over the counter monograph drugs | March 25, 2002 |
| Marc Glassman, Inc. | 1 | tablet, delayed release | Over the counter monograph drugs | July 1, 2014 |
| Meijer, Inc. | 1 | tablet, delayed release | Over the counter monograph drugs | March 24, 2025 |
| Nuvicare LLC | 1 | tablet, coated | Over the counter monograph drugs | March 2, 2026 |
| Padagis US LLC | 1 | suppository | Over the counter monograph drugs | September 1, 1990 |
| Pioneer Life Sciences, LLC | 1 | tablet, coated | Over the counter monograph drugs | March 2, 2026 |
| Raritan Pharmaceuticals Inc | 1 | tablet, coated | Over the counter monograph drugs | October 29, 2019 |
| Sda Laboratories, Inc. | 1 | tablet | Over the counter monograph drugs | July 1, 2025 |
| Simpex Pharma Pvt. Ltd | 1 | tablet, coated | Over the counter monograph drugs | February 9, 2018 |
| Sportpharm LLC | 1 | tablet | Over the counter monograph drugs | February 6, 2026 |
| Stratus Pharmaceuticals Inc | 1 | suppository | Over the counter monograph drugs | May 30, 2014 |
| Time Cap Laboratories, Inc | 1 | tablet, delayed release | Over the counter monograph drugs | April 1, 2014 |
| Topco Associates LLC | 1 | tablet, delayed release | Over the counter monograph drugs | April 20, 2024 |
| Topco Associates LLC | 1 | tablet, delayed release | Over the counter monograph drugs | May 15, 2019 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet, delayed release | Over the counter monograph drugs | April 1, 2013 |
| Valley Medical Products, LLC | 1 | capsule, coated | Over the counter monograph drugs | December 1, 2025 |
| Walmart Inc. | 1 | tablet, delayed release | Over the counter monograph drugs | December 27, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, delayed release | 54 | 48.2% |
| Suppository | 24 | 21.4% |
| Tablet, coated | 16 | 14.3% |
| Tablet | 14 | 12.5% |
| Tablet, film coated | 1 | 0.9% |
| Capsule, coated | 1 | 0.9% |
| Capsule, liquid filled | 1 | 0.9% |
| Enema | 1 | 0.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 112 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Stimulant Laxative | 112 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.